These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 8750621)
1. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. Martyré MC Leuk Lymphoma; 1995 Dec; 20(1-2):39-44. PubMed ID: 8750621 [TBL] [Abstract][Full Text] [Related]
2. Involvement of the fibrogenic cytokines, TGF-beta and bFGF, in the pathogenesis of idiopathic myelofibrosis. Le Bousse-Kerdilès MC; Martyré MC; Pathol Biol (Paris); 2001 Mar; 49(2):153-7. PubMed ID: 11317961 [TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders. Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648 [TBL] [Abstract][Full Text] [Related]
4. Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis. Le Bousse-Kerdilès MC; Martyré MC Ann Hematol; 1999 Oct; 78(10):437-44. PubMed ID: 10550553 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic criteria of the myeloproliferative disorders (MPD): essential thrombocythaemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia. Michiels JJ Neth J Med; 1997 Aug; 51(2):57-64. PubMed ID: 9286142 [TBL] [Abstract][Full Text] [Related]
6. Megakaryocytes and platelets in myeloproliferative disorders. Briere J; Kiladjian JJ; Peynaud-Debayle E Baillieres Clin Haematol; 1997 Feb; 10(1):65-88. PubMed ID: 9154316 [TBL] [Abstract][Full Text] [Related]